Personalized iTBS in Real-World Clinical Settings for Schizophrenia
RecruitingNCT07176468Phase: NAStarted 2025-10-20
Summary
This study is designed to determine whether neuronavigation-guided, personalized Intermittent Theta-Burst Stimulation (iTBS) can produce clinically benefits for patients with schizophrenia when delive
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
60 Years
Locations
Anhui Medical UniversityHefei, Anhui, China
Anhui Medical UniversityHefei, Anhui, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07176468